Fig. 1From: SLIT2 promoter hypermethylation predicts disease progression in chronic myeloid leukemiaRelative SLIT2 promoter methylation level in controls and CML patients. SLIT2 promoter methylation was detected by RT-qMSP in controls and whole CML patients as well as different stages of CML patients (CP stage, AP sage, and BC stage) were presented with scatter plots. The median level of SLIT2 promoter methylation in each group was shown with horizontal lineBack to article page